STOCK TITAN
  1. Home
  2. Sec-filings
  3. NOVT
  4. [Form 4] NOVANTA INC Insider Trading Activity

Novanta Inc. (NOVT) CEO sells 323 shares under 10b5-1 trading plan

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Novanta Inc. Chief Executive Officer and director Matthijs Glastra reported a small insider sale of company stock. On January 8, 2026, he sold 323 shares of Novanta Inc. common stock at a weighted-average price of $130.14 per share, coded as an open market sale. The transaction was carried out under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025, which is designed to allow automated trading according to preset instructions.

Following this sale, Glastra beneficially owns 85,044 shares directly and an additional 54,382 shares indirectly through the Matthijs Glastra 2021 Irrevocable Trust, for which his spouse serves as trustee.

Positive

  • None.

Negative

  • None.
Insider Glastra Matthijs
Role Chief Executive Officer
Sold 323 shs ($42K)
Type Security Shares Price Value
Sale Common Stock 323 $130.14 $42K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 85,044 shares (Direct); Common Stock — 54,382 shares (Indirect, Matthijs Glastra 2021 Irrevocable Trust)
Footnotes (1)
  1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee. This transaction was executed in multiple trades ranging from $130.06 to $130.23. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Glastra Matthijs
(Last) (First) (Middle)
C/O NOVANTA INC.
125 MIDDLESEX TURNPIKE
(Street)
BEDFORD MA 01730
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NOVANTA INC [ NOVT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/08/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/08/2026 S(1) 323 D $130.14(2) 85,044 D
Common Stock 54,382 I Matthijs Glastra 2021 Irrevocable Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.
2. This transaction was executed in multiple trades ranging from $130.06 to $130.23. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks:
Power of Attorney on file
/s/ John Burke, Attorney-in-Fact 01/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Novanta (NOVT) report for its CEO?

Novanta Inc. reported that its Chief Executive Officer and director Matthijs Glastra sold 323 shares of Novanta common stock on January 8, 2026 in an open market transaction.

At what price were the Novanta (NOVT) shares sold in this Form 4 filing?

The 323 shares of Novanta common stock were sold at a weighted-average price of $130.14 per share, based on multiple trades ranging from $130.06 to $130.23.

Was the Novanta (NOVT) CEO sale under a Rule 10b5-1 trading plan?

Yes. The filing states the sales were effected under a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person’s spouse is a trustee.

How many Novanta (NOVT) shares does CEO Matthijs Glastra own after the reported sale?

After the reported transaction, Matthijs Glastra beneficially owns 85,044 shares directly and 54,382 shares indirectly through the Matthijs Glastra 2021 Irrevocable Trust.

Does the Form 4 indicate indirect ownership for Novanta (NOVT) shares?

Yes. The Form 4 lists 54,382 Novanta common shares as held indirectly through the Matthijs Glastra 2021 Irrevocable Trust, which is referenced in the ownership table.

Who is the reporting person in this Novanta (NOVT) Form 4 filing and what is their role?

The reporting person is Matthijs Glastra, who is identified in the filing as both a director and the Chief Executive Officer of Novanta Inc.